title: The Virginia Mason approach to localized pancreatic cancer.
abstract: This article describes the approaches presently employed at Virginia Mason Medical Center for treatment of localized pancreatic cancer, including preoperative staging, operative intervention, incorporation of adjuvant therapy, and supportive care.
authors.affiliation: Section of Hematology-Oncology, Virginia Mason Medical Center, 1100 9th Avenue, Seattle, WA 98111, USA. Vincent.Picozzi@vmmc.org
authors.forename: Vincent J
authors.initials: VJ
authors.lastname: Picozzi
authors.forename: L William
authors.initials: LW
authors.lastname: Traverso
mesh_terms: D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010180:Pancreatectomy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D011300:Preoperative Care / Q000379:methods; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D014861:Washington
chemical_list: D016898:Interferon-alpha; D002945:Cisplatin; D005472:Fluorouracil